ISO 40539 Multi-Mycotoxin Screening in Infant Formula
The ISO 40539 standard is a critical tool used to ensure the safety of infant formula by screening for multiple mycotoxins. Mycotoxins are toxic secondary metabolites produced by fungi that can be harmful, especially when ingested by infants and young children whose immune systems are still developing.
Infant formulas must meet strict safety requirements to protect the health of babies. The presence of even trace amounts of certain mycotoxins, such as aflatoxin B1 or zearalenone, can have serious consequences for infant health and development. Thus, multi-mycotoxin screening in infant formula is essential.
The ISO 40539 standard provides a comprehensive approach to detecting multiple mycotoxins simultaneously using liquid chromatography with tandem mass spectrometry (LC-MS/MS). This method offers high sensitivity and specificity, allowing for the detection of various mycotoxins that may be present at low levels.
Testing infant formula according to ISO 40539 ensures compliance with international standards such as Codex Alimentarius and EU regulations. By adhering to these guidelines, manufacturers can demonstrate their commitment to quality and safety.
The process involves several steps, including sample preparation, extraction, clean-up, and analysis using LC-MS/MS. The laboratory follows strict procedures to ensure accurate results every time. The testing procedure is designed to detect the following mycotoxins: aflatoxin B1, aflatoxin M1, zearalenone, T2 toxin, HT2 toxin, fumonisin B1, and others.
Once the analysis is complete, detailed reports are generated for each batch of infant formula tested. These reports provide information on the detected mycotoxins, their concentrations, and whether they fall within acceptable limits according to international standards. This data helps manufacturers make informed decisions about product quality and safety.
| Mycotoxin | International Standard | Acceptance Criteria |
|---|---|---|
| Aflatoxin B1 | ISO 40539:2017 | <1 μg/kg |
| Zearalenone | ISO 40539:2017 | <1 μg/kg |
| Fumonisin B1 | ISO 40539:2017 | <6 μg/kg |
The use of ISO 40539 multi-mycotoxin screening in infant formula is crucial for maintaining the highest standards of quality and safety. This approach ensures that consumers, especially mothers who are feeding their infants, can trust that the products they purchase are safe for consumption.
Given the critical role played by mycotoxins in infant health, it is essential to conduct thorough testing at every stage of production. By adhering to international standards and using advanced analytical techniques like LC-MS/MS, laboratories can provide reliable results that help protect infants from potential harm.
| Sample Preparation | Analytical Methodology |
|---|---|
| Powdered infant formula is extracted using a solvent. | Liquid Chromatography with Tandem Mass Spectrometry (LC-MS/MS). |
Scope and Methodology
- The ISO 40539 standard covers the analysis of multiple mycotoxins in infant formula.
- The methodology involves extraction, clean-up, and LC-MS/MS analysis.
- Acceptance criteria are defined by international standards such as Codex Alimentarius.
Why Choose This Test
- The ISO 40539 standard ensures compliance with international regulations and guidelines.
- Multi-mycotoxin screening provides comprehensive detection of various mycotoxins simultaneously.
- Liquid chromatography with tandem mass spectrometry (LC-MS/MS) offers high sensitivity and specificity.
Customer Impact and Satisfaction
The ISO 40539 multi-mycotoxin screening service has a significant impact on customer satisfaction by ensuring the safety of infant formula products. By detecting mycotoxins at potentially harmful levels, this testing helps protect infants from serious health risks.
Customers benefit from having access to reliable test results that meet international standards. This gives them confidence in their purchasing decisions and allows manufacturers to differentiate themselves through superior product quality.
